SG Americas Securities
DCPH

SG Americas Securities’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

SG Americas Securities’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-43,724
Closed -$705K – 3565
2023
Q4 		$705K Sell
43,724
-121,292
-74% -$1.55M 0.01% 1254
2023
Q3 		$2.1M Buy
165,016
+12,042
+8% +$166K 0.02% 693
2023
Q2 		$2.15M Buy
152,974
+136,257
+815% +$1.95M 0.02% 707
2023
Q1 		$258K Buy
16,717
+7,197
+76% +$120K ﹤0.01% 2229
2022
Q4 		$156K Sell
9,520
-11,316
-54% -$184K ﹤0.01% 2405
2022
Q3 		$385K Sell
20,836
-20,747
-50% -$326K ﹤0.01% 1777
2022
Q2 		$547K Buy
+41,583
New +$459K 0.01% 1887
2021
Q4 		– Sell
-8,552
Closed -$291K – 3906
2021
Q3 		$291K Sell
8,552
-1,207
-12% -$38.5K ﹤0.01% 2968
2021
Q2 		$357K Sell
9,759
-4,540
-32% -$176K ﹤0.01% 2095
2021
Q1 		$641K Buy
14,299
+10,301
+258% +$480K ﹤0.01% 1838
2020
Q4 		$228K Sell
3,998
-46,370
-92% -$2.75M ﹤0.01% 2556
2020
Q3 		$2.58M Buy
50,368
+47,520
+1,669% +$2.33M 0.02% 604
2020
Q2 		$170K Sell
2,848
-1,512
-35% -$80.9K ﹤0.01% 2982
2020
Q1 		$180K Buy
4,360
+1,385
+47% +$76.9K ﹤0.01% 2577
2019
Q4 		$185K Buy
+2,975
New +$141K ﹤0.01% 2538
2018
Q3 		– Sell
-8,495
Closed -$334K – 3517
2018
Q2 		$334K Buy
8,495
+919
+12% +$27.1K ﹤0.01% 2294
2018
Q1 		$152K Buy
+7,576
New +$192K ﹤0.01% 2632
2017
Q4 		– Sell
-7,544
Closed -$143K – 3725
2017
Q3 		$143K Buy
+7,544
New +$138K ﹤0.01% 2896

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

SG Americas Securities's DCPH Position: Q1 2024 in Review

SG Americas Securities sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 43,724 shares — an estimated $705K sold.

SG Americas Securities first reported a position in DCPH in Q3 2017 and held it in 18 quarters. The position peaked at $2.58M in Q3 2020. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • SG Americas Securities reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • SG Americas Securities sold 43,724 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $705K.
  • SG Americas Securities first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 18 quarters.
  • SG Americas Securities's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.58M in Q3 2020.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.